Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on February 14, 2008. The filing addresses a Regulation FD Disclosure regarding the termination of an existing Rule 10b5-1 trading plan and the adoption of a new plan by Russell C. Horowitz, the company's Chairman and Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on insider trading plan modifications and does not contain financial performance data.
Material Changes
- Termination of Prior Plan: Mr. Horowitz is terminating his previous Rule 10b5-1 sales plan, adopted in February 2006, effective February 20, 2008. There were 780,000 shares remaining unsold under this prior plan.
- Adoption of New Plan: A new Rule 10b5-1 plan is being established effective February 20, 2008, to facilitate the sale of up to 900,000 shares of Marchex common stock.
- Ownership Impact: The maximum sale under the new plan represents approximately 9% of Mr. Horowitz's current holdings, 3% of outstanding Class B common stock, and 2% of total outstanding common stock.
Guidance, Outlook, and Risks
Plan Parameters: Sales under the new plan will commence no earlier than December 1, 2008, and will occur over a 12-month period. The plan includes specific contingencies, such as minimum stock price requirements, and mandates public disclosure of sales via SEC filings.
Purpose: The plan is designed for long-term asset diversification and liquidity strategies, allowing the CEO to minimize market impact by spreading sales over time while not in possession of material non-public information.
Legal Disclaimer: The information in this report is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other registration statements unless expressly referenced.
Investor Verification Checklist
- Verify the exact commencement date of sales under the new plan (no earlier than December 1, 2008).
- Monitor future Form 4 filings to track actual share sales against the 900,000 share maximum.
- Confirm the specific minimum stock price contingencies attached to the new plan, as these were not detailed in this filing.
- Review the status of the 780,000 shares remaining from the terminated 2006 plan to ensure they are not sold outside the new plan's parameters.